Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c167 |
|---|---|
| Identifier | NCT05611671 |
| Trial Title | A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Diseases|Colitis, Ulcerative |
| Interventions | DRUG: MORF-057|DRUG: Placebo |
Participant Information
| Sponsor | Morphic Therapeutic, Inc |
|---|---|
| City | Sun City |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2022-10-31 |
|---|---|
| Primary Completion Date | 2024-11-28 |
| Completion Date | 2025-08-26 |